Ofloxacin versus doxycycline in gynecological infections.
Anna Schneider, E. R. Weißenbacher, K. Gutschow, Isolde Wachter
Abstract
Anna Schneider, E. R. Weißenbacher, K. Gutschow, Isolde Wachter
Abstract
40 patients were investigated with either ofloxacin (2 X 20 mg/7d) or doxycycline (2 X 100 mg/7d). E. coli (28 from 61 strains) was the predominant strain isolated. Microbiological efficacy: 51 from 61 strains were eliminated: 29 from 32 strains in the ofloxacin group and 22 from 29 strains in the doxycycline group. Two patients in the ofloxacin and four in the doxycycline group were not cured. There were two side effects (sickness) in the doxycycline and two in the ofloxacin group.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
40 patients were investigated with either ofloxacin (2 X 20 mg/7d) or doxycycline (2 X 100 mg/7d). E. coli (28 from 61 strains) was the predominant strain isolated. Microbiological efficacy: 51 from 61 strains were eliminated: 29 from 32 strains in the ofloxacin group and 22 from 29 strains in the doxycycline group. Two patients in the ofloxacin and four in the doxycycline group were not cured. There were two side effects (sickness) in the doxycycline and two in the ofloxacin group.
Key concepts: Ofloxacin, Doxycycline, Microbiology, Medicine, Antibiotics, Antibacterial agent, Biology, Ciprofloxacin